Maravai LifeSciences (MRVI) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Circular Clean Climate Climate Change Contaminant Emission Environment Environmental Environmental Protection Extraction Hazard Intensity Life Cycle Lifecycle Materials Nature Nuclear Ocean Offset Package Packaging Pandemic Pollution Raw Materials Toxic Waste Access African American Asian Benefits Black California Consumer Privacy Act Charitable Collective Bargaining Community Culture Customer Cyber Cyber Security Cybersecurity Data Privacy Data Security Demographic Disability Diversity Diversity and Inclusion Employee Employee Engagement Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Injuries Injury Labor Condition Latinx LGBTQ Paid Leave Privacy Product Quality Recall Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Stakeholder Supplier Supply Chain Talent Training Union Volunteer Workforce Anti-corruption Assessment Assurance Audit Bonus Bribery Classified Classified Board Clawback Commitment Conflict of Interest Corporate Governance Corruption Department of ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovate Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Mission Oversee Oversight Pledging Procurement Proxy Contest Purpose Quality Standard R&D Reputation Reputational Research and Development Responsibility Responsible Shareholder Proposals Stewardship Strategy Supermajority Sustainability Sustainable Targets Tax Tenure Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On May 12, 2022, the Company held its 2022 Annual Meeting of Shareholders (the “Annual Meeting”). On March 15, 2022, the record date of the Annual Meeting, the Company had an aggregate of 255,158,736 shares of common stock issued and outstanding, consisting of 131,489,540 shares of Class A Common Stock and 123,669,196 shares of Class B Common Stock (together, the “Common Stock”). The holders of a total of 238,234,280 shares of Common Stock were present at the Annual Meeting, either in person or by proxy, which constituted a quorum for the purpose of conducting business at the Annual Meeting.

Set forth below are the final voting results for each proposal submitted to a vote of the shareholders at the Annual Meeting.

Proposal No. 1: Election of directors.

The Company’s shareholders elected the following nominees for director to serve as Class II directors for a three-year term expiring at the Company’s 2025 annual meeting of shareholders and until their successors are duly elected and qualified.

Nominee	Votes For	Votes Withheld	Broker Non-Votes

Sean Cunningham	211,485,119	23,081,174	3,667,986
Robert B. Hance	212,885,917	21,680,376	3,667,986
Jessica Hopfield	206,780,637	27,785,656	3,667,986
Murali K. Prahalad	212,884,636	21,681,657	3,667,986

Proposal No. 2: Proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022.

The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022 was ratified.


Votes For	Votes Against	Abstentions
238,213,319	9,858	11,102

Proposal No. 3: Proposal to recommend, on a non-binding advisory basis, the frequency of future shareholder advisory votes on the compensation of the Company’s named executive officers.

The Company’s shareholders recommended, on a non-binding advisory basis, to hold future advisory votes on the compensation of the Company’s named executive officers (“say-on-pay”) every year.

Votes For Every Year			Votes for Every Two Years			Votes for Every Three Years			Abstentions			Broker Non-Votes

234,384,783			21,882			136,741			22,888			3,667,986

The Company’s board of directors (the “Board”) has considered the outcome of this advisory vote and has determined that say-on-pay votes will be conducted every year. The Board will re-evaluate this determination after the next shareholder advisory vote on the frequency of the say-on-pay vote (which will be at the Company’s 2028 annual meeting of shareholders unless presented earlier).